Receptive Bio is a biotechnology company focused on novel next-generation blood-brain barrier shuttles targeting novel receptors to enable selective and effective delivery of therapeutics to the brain
Receptive Bio is a biotechnology company focused on novel next-generation blood-brain barrier shuttles targeting novel receptors to enable selective and effective delivery of therapeutics to the brain. Receptive is building a portfolio of CNS therapeutics including advancing a lead program in Alzheimer’s disease that is rapidly progressing toward the clinic.